NCT04863417View on ClinicalTrials.gov

Study to Evaluate the Safety, Local and Systemic Tolerability, and Pharmacokinetics of Multiple-Dose Topical Administration of PF-07038124 in Japanese Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 30, 2021

Primary Completion Date

September 9, 2021

Study Completion Date

September 9, 2021

Conditions
Healthy
Interventions
DRUG

PF-07038124 or vehicle

PF-07038124 0.01% or vehicle Ointment QD applied to 2000 cm2 Body Surface Area

DRUG

PF-07038124 or vehicle

PF-07038124 0.01% or vehicle Ointment QD applied to 4000 cm2 Body Surface Area

Trial Locations (1)

192-0071

P-one clinic, Keikokai medical corporation, Hachiōji

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT04863417 - Study to Evaluate the Safety, Local and Systemic Tolerability, and Pharmacokinetics of Multiple-Dose Topical Administration of PF-07038124 in Japanese Healthy Participants | Biotech Hunter | Biotech Hunter